News

 

 

Funding: New Awards

James D. Gorhan, MD
Member, Immunology and Cancer Immunotherapy
Norris Cotton Cancer Center
Associate Professor of Pathology; Microbiology & Immunology
Agency: National Institute of Allergy and Infectious Diseases
Chemokines in Autoimmune Hepatitis

Elliot S. Fisher, MD, MPH
Member, Cancer Control
Norris Cotton Cancer Center
Professor of Medicine
Agency: California Health Care Foundation
Dartmouth Atlas Project, Phase II

Gary N. Schwartz, MD
Member, Molecular Therapeutics
Norris Cotton Cancer Center
Professor of Medicine
Agency: Wyeth Pharmaceuticals
A Phase Study of HKI-272 in Combination With Vinorelbine in Subjects With Solid Tumors and Metastatic Breast cancer

Agency: ImClone Systems Incorporated
A Phase 2 Randomized, Multicenter Study of IMC-A12 as a Single Agent or in Combination With Antiestrogens in Postmenopausal Women With Hormone Receptor-Positive Advanced or Metastatic Breast Cancer After Progression on Antiestrogen Therapy

Peter A. Kaufman, MD
Member, Molecular Therapeutics
Norris Cotton Cancer Center
Associate Professor of Medicine
Agency: Genentech, Inc.
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Pertuzumab & Trastuzumab + Docetaxel Vs. Trastuzumab

Agency: Amgen
A Randomized, 4-Arm, Placebo-Controlled Phase 2 Trial of AMG 386 in Combination with Bevacizumab and Paclitaxel or AMG 386 Plus Paclitaxel as First-Line Therapy in Subjects With Her2-Negative, Metastatic or Locally Recurrent Breast Cancer

J. Marc Pipas, MD
Member, Molecular Therapeutics
Norris Cotton Cancer Center
Associate Professor of Medicine
Agency: Fibrogen, Inc.
A Phase 1 Study of Safety and Bioactivity with FG-3019 in Combination with Gemcitabine and Erlotinib for Subjects with Locally Advanced or Metastatic Pancreatic Cancer

Camilo E. Fadul, MD
Member, Immunology and Cancer Immunotherapy
Norris Cotton Cancer Center
Associate Professor of Medicine
Agency: Dana-Farber Cancer Institute, Inc.
Phase II Study of Dose Intense Temozolomide in Recurrent GBM